Loading stock analysis…
Evidence Synthesis
Last synthesized: 9 Jul 2026, 00:52
Narrative updating · score is newerEvidence Synthesis
AstraZen's 39.33% gross margin accelerated to, up from 9.56%.
Revenue growth yoy accelerated to .4%, up from -23%. Eps actual accelerated to .68 INR, up from 3.83 INR. AstraZen's daily volume decelerated to 1429 shares, down from 9442 shares. The close price decelerated to 8180 INR, down from 8204 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 39.33 % | 9.56 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 9.56 % | 8.24 | ▲ |
| REVENUE_GROWTH_YOY | 20.4 % | -23 | ▲ |
| EPS_ACTUAL | 10.68 INR | 3.83 | ▲ |
| EPS_SURPRISE_PERCENT | 0.133 % | -0.538 | ▲ |
| PRICE_CHANGE_PERCENT | -0.293 % | — | - |
| DAILY_VOLUME | 1,429 shares | 9,442 | ▼ |
| CLOSE_PRICE | 8,180 INR | 8,204 | ▼ |